Inova Heart and Vascular Institute Recruiting Patients for AFib Stroke Prevention Device Clinical Trial

Matthew W. Sherwood, MD, MHS, is an Inova interventional cardiologist, Director of Inova’s Left Atrial Appendage Closure/WATCHMAN Program and Co-Director of Inova’s Structural Heart Disease Program. Dr. Sherwood is board-certified in interventional cardiology, cardiovascular disease and internal medicine. Millions of Americans have atrial fibrillation (AFib) and take oral anticoagulant medication (blood thinners) every day. These…

Read More

Stroke Reduction Device Offers Hope to At-Risk AFib Patients on Blood Thinners

illustration of a heart with EKG readings on top

Inova Heart and Vascular Institute Among the First to Use Next-Generation WATCHMAN FLX™ Device for Stroke Reduction Inova Heart and Vascular Institute (IHVI) clinicians are among the first in the Washington, DC region to implant a next-generation stroke risk reduction device for patients with atrial fibrillation (AFib). AFib is an irregular heartbeat that affects as…

Read More

Inova Gets Heart Smart

Dudley family with Inova leaders

Inova celebrates the Dudley family gift for the Center for Cardiovascular Innovation In December 2018, Inova held an event to honor a donation to create The Dudley Center for Cardiovascular Innovation. The Dudley Family Foundation partnered with Inova Heart and Vascular Institute (IHVI) to develop the new institution, a state-of-the-art center to encourage innovation and…

Read More